E-LIB Suche - Ergebnisse für: Feng, Chaoling

1

Health Care Resource Utilization and Total Costs of Care fo..:

Ito, Diane ; Feng, Chaoling ; Fu, Christine...
Clinical Therapeutics. 46 (2024) 1 - p. 3-11 , 2024

Link: https://doi.org/10.1016/..

2

Hospital healthcare resource utilization and costs for chim..:

Cui, Chendi ; Feng, Chaoling ; Rosenthal, Ning...
Leukemia & Lymphoma. 65 (2024) 7 - p. 922-931 , 2024

Link: https://doi.org/10.1080/..

3

Chimeric Antigen Receptor T-Cell Access in Patients with Re..:

Ahmed, Nausheen ; Sun, Fang ; Teigland, Christie...
Transplantation and Cellular Therapy. 30 (2024) 7 - p. 714-725 , 2024

Link: https://doi.org/10.1016/..

4

Matching-Adjusted Indirect Comparison of Brexucabtagene Aut..:

Salles, Gilles ; Chen, Jenny M. H. ; Zhang, Ina...
Advances in Therapy. 41 (2024) 5 - p. 1938-1952 , 2024

Link: https://doi.org/10.1007/..

5

Matching-Adjusted Indirect Comparisons of Brexucabtagene Au..:

Shah, Bijal ; Chen, Jenny M. H. ; Wu, James J....
Advances in Therapy. 40 (2023) 12 - p. 5383-5398 , 2023

Link: https://doi.org/10.1007/..

6

Health resource utilization and costs of care for adult pat..:

Ito, Diane ; Feng, Chaoling ; Fu, Christine...
Expert Review of Pharmacoeconomics & Outcomes Research. , 2023

Link: https://doi.org/10.1080/..

7

An updated cost-effectiveness analysis of axicabtagene cilo..:

Oluwole, Olalekan O. ; Patel, Anik R. ; Vadgama, Sachin...
Journal of Medical Economics. 27 (2023) 1 - p. 77-83 , 2023

Link: https://doi.org/10.1080/..

8

Cost-effectiveness of axicabtagene ciloleucel versus lisoca..:

Oluwole, Olalekan O. ; Liu, Rongzhe ; Diakite, Ibrahim...
Journal of Medical Economics. 25 (2022) 1 - p. 541-551 , 2022

Link: https://doi.org/10.1080/..

9

Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refr..:

Shah, Bijal D. ; Smith, Nathaniel J. ; Feng, Chaoling...
Advances in Therapy. 39 (2022) 8 - p. 3678-3695 , 2022

Link: https://doi.org/10.1007/..

10

ALL-190: Cost-Effectiveness of KTE-X19 for Adult Patients w..:

Shah, Bijal ; Smith, Nathaniel ; Raad, Angie...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S272-S273 , 2021

Link: https://doi.org/10.1016/..

11

Poster: ALL-190: Cost-Effectiveness of KTE-X19 for Adult Pa..:

Shah, Bijal ; Smith, Nathaniel ; Raad, Angie...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S207 , 2021

Link: https://doi.org/10.1016/..

12

KTE-X19 for relapsed or refractory adult B-cell acute lymph..:

Shah, Bijal D ; Ghobadi, Armin ; Oluwole, Olalekan O...
The Lancet. 398 (2021) 10299 - p. 491-502 , 2021

Link: https://doi.org/10.1016/..

13

Association Between Prior Insurance and Health Service Util..:

Shi, Lu ; Francis, Ellen C. ; Feng, Chaoling..
Health Equity. 3 (2019) 1 - p. 409-416 , 2019

Link: https://doi.org/10.1089/..

14

Length of stay, mortality, and readmissions among Medicare ..:

Demiralp, Berna ; Koenig, Lane ; Kala, Jaya...
ClinicoEconomics and Outcomes Research. 11 (2019) - p. 129-144 , 2019

Link: https://doi.org/10.2147/..

15

Sa1711 - Real World Comparative Risk of Serious Infection w..:

Osterman, Mark T. ; Long, Millie D. ; Singh, Siddharth...
Gastroenterology. 154 (2018) 6 - p. S-365 , 2018

Link: https://doi.org/10.1016/..